Related references
Note: Only part of the references are listed.Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors
Hao Zheng et al.
DRUG DELIVERY (2023)
Evolutionary analysis of replicator dynamics about anti-cancer combination therapy
Rujing Zhao et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2023)
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
Jinguo Zhang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial
Nicholas J. Vogelzang et al.
JAMA ONCOLOGY (2022)
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Glycosphingolipids (GSLs) from Sphingomonas paucimobilis Increase the Efficacy of Liposome-Based Nanovaccine against Acinetobacter baumannii-Associated Pneumonia in Immunocompetent and Immunocompromised Mice
Masood Alam Khan et al.
MOLECULES (2022)
Linear DNA amplicons as a novel cancer vaccine strategy
Antonella Conforti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Neutrophils: Musketeers against immunotherapy
Kashif Rafiq Zahid et al.
FRONTIERS IN ONCOLOGY (2022)
Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer
Matthew D. Kerr et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Good cops turn bad: The contribution of neutrophils to immune-checkpoint inhibitor treatment failures in cancer
Huajia Zhang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
Sundee Dees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients
Elham Safarzadeh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Rodolfo L. Chavez-Dominguez et al.
FRONTIERS IN ONCOLOGY (2021)
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Kai Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner
Fan Yang et al.
BIOACTIVE MATERIALS (2021)
Metronomic Chemotherapy
Marina Elena Cazzaniga et al.
CANCERS (2021)
Neutrophil Extracellular Traps: A New Player in Cancer Metastasis and Therapeutic Target
Dakai Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Vaccinations and Autoimmune Diseases
Bianca Olivieri et al.
VACCINES (2021)
Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
Howard Donninger et al.
VACCINES (2021)
A historical perspective of liposomes-a bio nanomaterial
Vikash Kumar Sharma et al.
MATERIALS TODAY-PROCEEDINGS (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
Atsushi Tanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
Steve Boudewijns et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Results of a Randomized Phase IIb Trial of Nelipepimut-S thorn Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer
G. Travis Clifton et al.
CLINICAL CANCER RESEARCH (2020)
Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer
Jamshid Gholizadeh Navashenaq et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
Anna Lucia Tornesello et al.
CANCERS (2020)
Dendritic cell therapy in cancer treatment; the state-of-the-art
Mahsa Sadeghzadeh et al.
LIFE SCIENCES (2020)
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Masanori Oshi et al.
CANCERS (2020)
The Resistance Mechanisms of Lung Cancer Immunotherapy
Fen Wang et al.
FRONTIERS IN ONCOLOGY (2020)
The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines
Benjamin Gordon et al.
VACCINES (2020)
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Kristian M. Hargadon
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing et al.
IMMUNITY (2019)
Cancer Vaccines
Peter J. DeMaria et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
Iris Koske et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Immunologic responses in triple-negative breast cancer patients in a randomized phase IIb trial of nelipepimut-S plus trastuzumab versus trastuzumab alone to prevent recurrence.
Jessica Campf et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Howard West et al.
LANCET ONCOLOGY (2019)
Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response
Zhang Huiyong et al.
VACCINE (2019)
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
Qiuhua Luo et al.
CANCER LETTERS (2019)
Immunogenic cell death in cancer therapy: Present and emerging inducers
Jingyi Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India
Sudha Sivaram et al.
LANCET ONCOLOGY (2018)
Liposomal Drug Delivery Systems and Anticancer Drugs
Temidayo O. B. Olusanya et al.
MOLECULES (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting Wnt/β-Catenin Signaling for Cancer Immunotheraoy
Bojun Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Peptide-Based Immunotherapeutics and Vaccines 2017
Pedro Reche et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Potentiating cancer vaccine efficacy in liver cancer
Maria Tagliamonte et al.
ONCOIMMUNOLOGY (2018)
Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy
Wen-Hui Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
DNA Vaccine: Methods and Mechanisms
Saber Soltani et al.
ADVANCES IN HUMAN BIOLOGY (2018)
The dawn of vaccines for cancer prevention
Olivera J. Finn
NATURE REVIEWS IMMUNOLOGY (2018)
Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.
Tanguy Y. Seiwert et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
The importance of correctly timing cancer immunotherapy
Elham Beyranvand Nejad et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma
Qiu Xia et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model
Dong Jin et al.
IMMUNOTHERAPY (2017)
NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC
Camilla Rydberg Millrud et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
Kai Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model
Xiulan Lai et al.
PLOS ONE (2017)
New Immunotherapy Strategies in Breast Cancer
Lin-Yu Yu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2017)
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
Nicole Rufo et al.
TRENDS IN CANCER (2017)
Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model
Sayyed Nilofar Danishmalik et al.
DNA AND CELL BIOLOGY (2017)
Peptide vaccines in cancer - old concept revisited
Takumi Kumai et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators
Hilmar Weinmann
CHEMMEDCHEM (2016)
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
Mutsunori Murahashi et al.
CLINICAL IMMUNOLOGY (2016)
Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+T Cells
Michal Kuczma et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2016)
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
Elisabeth Quoix et al.
LANCET ONCOLOGY (2016)
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Marij J. Welters et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth
Stella Arelaki et al.
PLOS ONE (2016)
Future perspectives in cancer immunotherapy
Marinos Tsiatas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines
Shigeo Koido
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
Maria Tagliamonte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Sijumon Kunjachan et al.
CHEMICAL REVIEWS (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Vaccines for tumor prevention: a pipe dream?
Guido Forni
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
Eveline M. Dijkgraaf et al.
ONCOTARGET (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
Neil L. Berinstein et al.
ONCOIMMUNOLOGY (2015)
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer A Randomized Clinical Trial
Christopher R. Heery et al.
JAMA ONCOLOGY (2015)
Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Tetje C. van der Sluis et al.
CLINICAL CANCER RESEARCH (2015)
New insights into metronomic chemotherapy-induced immunoregulation
Yi-Bin Hao et al.
CANCER LETTERS (2014)
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries
Kalipso Chalkidou et al.
LANCET ONCOLOGY (2014)
Combination of chemotherapy and immunotherapy for colon cancer in China: A meta-analysis
Zheng-Xu Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Vaccines for Cancer Prevention: A Practical and Feasible Approach to the Cancer Epidemic
Olivera J. Finn
CANCER IMMUNOLOGY RESEARCH (2014)
Trial Watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2014)
Metronomic chemotherapy
Rituparna Maiti
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
M. Reck et al.
ANNALS OF ONCOLOGY (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Chemoimmunotherapy: reengineering tumor immunity
Gang Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trial
Richard Harrop et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Cancer immunotherapies, their safety and toxicity
Gheath Alatrash et al.
EXPERT OPINION ON DRUG SAFETY (2013)
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis
Huan Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2
Heng-Xiu Yan et al.
ONCOLOGY REPORTS (2013)
Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours
M. L. Wumkes et al.
VACCINE (2013)
Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination
Adam J. Litterman et al.
ONCOIMMUNOLOGY (2013)
Effects of conventional therapeutic interventions on the number and function of regulatory T cells
Mario Roselli et al.
ONCOIMMUNOLOGY (2013)
The global burden of cancer
Keyuri Popat et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2013)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
M. R. Shurin et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy
Benedetto Farsaci et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Thomas J. Lynch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
Melanie Demers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Recombinant viral vaccines for cancer
Ryan Cawood et al.
TRENDS IN MOLECULAR MEDICINE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses
Sofia R. Gameiro et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Viral Vector-Based Therapeutic Cancer Vaccines
Cecilia Larocca et al.
CANCER JOURNAL (2011)
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Stephen R. Mattarollo et al.
CANCER RESEARCH (2011)
Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
Paul J. Tacken et al.
SEMINARS IN IMMUNOLOGY (2011)
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
Xia Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
DNA Vaccines: Developing New Strategies against Cancer
Daniela Fioretti et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Cancer as a metabolic disease
Thomas N. Seyfried et al.
NUTRITION & METABOLISM (2010)
Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model
S. Julien et al.
BRITISH JOURNAL OF CANCER (2009)
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
Constantin N. Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Chemotherapy induces ATP release from tumor cells
Isabelle Martins et al.
CELL CYCLE (2009)
Immunotherapy of cancer
Hossein Borghaei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Combined modality immunotherapy and chemotherapy: a new perspective
Rupal Ramakrishnan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Cancer vaccines: Moving beyond current paradigms
Jeffrey Schlom et al.
CLINICAL CANCER RESEARCH (2007)
Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors
Daniela Rozkova et al.
CLINICAL IMMUNOLOGY (2006)
Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma
Yiwei Chi et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Lymphopenia: A new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma
L Claude et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
PB Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
Y Eralp et al.
BREAST CANCER RESEARCH (2004)
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects
HL Weiner et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
Share Paper
